BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36408923)

  • 1. Experiences with thermal ablation for cervical precancer treatment after self-collection HPV-based screening in the ASPIRE Mayuge randomized trial.
    Gottschlich A; Payne BA; Trawin J; Albert A; Jeronimo J; Mitchell-Foster S; Mithani N; Namugosa R; Naguti P; Orem J; Rawat A; Simelela PN; Singer J; Smith LW; van Niekerk D; Nakisige C; Ogilvie G
    Int J Cancer; 2023 Apr; 152(8):1630-1639. PubMed ID: 36408923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
    Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
    BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial.
    Pinder LF; Parham GP; Basu P; Muwonge R; Lucas E; Nyambe N; Sauvaget C; Mwanahamuntu MH; Sankaranarayanan R; Prendiville W
    Lancet Oncol; 2020 Jan; 21(1):175-184. PubMed ID: 31734069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
    Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
    Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting.
    Banerjee D; Mandal R; Mandal A; Ghosh I; Mittal S; Muwonge R; Lucas E; Basu P
    Asian Pac J Cancer Prev; 2020 May; 21(5):1391-1398. PubMed ID: 32458647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique.
    Salcedo MP; Lathrop E; Osman N; Neves A; Rangeiro R; Mariano AAN; Nkundabatware JC; Tivir G; Carrilho C; Monteiro ECS; Burny R; Thomas JP; Carns J; Andrade V; Mavume C; Paulo Mugolo R; Atif H; Hoover H; Chivambo E; Chissano M; Oliveira C; Milan J; Varon ML; Fellman BM; Baker E; Jeronimo J; Castle PE; Richards-Kortum R; Schmeler KM; Lorenzoni C
    Int J Gynecol Cancer; 2023 Dec; 33(12):1869-1874. PubMed ID: 37907263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
    Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
    Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
    Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
    Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.
    Baleydier I; Vassilakos P; Viñals R; Wisniak A; Kenfack B; Tsuala Fouogue J; Enownchong Enow Orock G; Lemoupa Makajio S; Foguem Tincho E; Undurraga M; Cattin M; Makohliso S; Schönenberger K; Gervaix A; Thiran JP; Petignat P
    PLoS One; 2021; 16(12):e0260776. PubMed ID: 34914727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
    Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
    BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial.
    Gottschlich A; Gondara L; Smith LW; Cook D; Martin RE; Lee M; Peacock S; Proctor L; Stuart G; Krajden M; Franco EL; van Niekerk D; Ogilvie G
    Int J Cancer; 2022 Sep; 151(6):897-905. PubMed ID: 35460070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
    Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
    BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa.
    Metaxas T; Kenfack B; Sormani J; Tincho E; Lemoupa Makajio S; Wisniak A; Vassilakos P; Petignat P
    BMC Cancer; 2022 Feb; 22(1):132. PubMed ID: 35109806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
    Chinula L; Topazian HM; Mapanje C; Varela A; Chapola J; Limarzi L; Stanley C; Hosseinipour M; Gopal S; Tang JH
    Int J Cancer; 2021 Jul; 149(2):371-377. PubMed ID: 33687746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
    Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.